Validation of trabectedin efficacy in patients with advanced soft tissue sarcoma

2 意见
administrator
administrator
07/18/23

Dr Axel Le Cesne, oncologist, sarcoma expert at Gustave Roussy, presents at ASCO 2018 the results of the T-SAR trial, comparing trabectedin vs best supportive care in patients with pretreated advanced soft tissue sarcoma.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个